Loading…
Invivyd, Inc. is projected to decline to $0.7496 by 2027, a -4% move from its current price of $0.7834. IVVD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.7413 | $0.7827 | $0.8264 | -0.09% |
| Jul 13 | $0.7241 | $0.782 | $0.8445 | -0.18% |
| Jul 14 | $0.711 | $0.7813 | $0.8585 | -0.27% |
| Jul 15 | $0.7001 | $0.7806 | $0.8703 | -0.36% |
| Jul 16 | $0.6906 | $0.7799 | $0.8807 | -0.45% |
| Jul 17 | $0.682 | $0.7791 | $0.8902 | -0.54% |
| Jul 18 | $0.6741 | $0.7784 | $0.8989 | -0.63% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6741 | $0.7784 | $0.8989 | -0.63% |
| Week 2 | $0.6311 | $0.7735 | $0.9481 | -1.26% |
| Week 3 | $0.5991 | $0.7686 | $0.9862 | -1.89% |
| Week 4 | $0.5727 | $0.7638 | $1.02 | -2.51% |
| Week 5 | $0.5501 | $0.7589 | $1.05 | -3.12% |
| Week 6 | $0.5301 | $0.7541 | $1.07 | -3.74% |
| Week 7 | $0.5121 | $0.7494 | $1.10 | -4.35% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Invivyd, Inc., with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children.
It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc.
in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut.
Invivyd, Inc. (IVVD) is a healthcare company currently trading with a price of $0.83. It has a market cap of $244.52M and is ranked 3667th. The stock trades in the healthcare sector with a focus on antibody therapies.
The price outlook shows a mixed path with near-term pressure but potential upside later in the forecast. The forecast implies a range of returns from negative to strong gains, including a high upside by 2050.
A major floor 39.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.7% away) — a key level to hold.
The nearest ceiling, 55.7% above — a clean break opens room to run.
A major ceiling 142.5% above — clearing it would confirm fresh momentum.
Key IVVD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IVVD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.8386 | Sell | $0.8276 | Sell |
| MA 10 | $0.8649 | Sell | $0.8554 | Sell |
| MA 20 | $0.8778 | Sell | $0.9029 | Sell |
| MA 50 | $1.09 | Sell | $1.07 | Sell |
| MA 100 | $1.34 | Sell | $1.28 | Sell |
| MA 200 | $1.68 | Sell | $1.40 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.89 | Neutral |
| Stoch RSI (14) | 5.22 | Buy |
| CCI (20) | -134.13 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -16.26 | Sell |
| Bollinger %B (20,2) | 0.08 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.06 | Sell |
| Awesome (5,34) | -0.13 | Sell |
| Ultimate (7,14,28) | 37.50 | Neutral |
| Momentum (10) | -0.10 | Sell |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 0.81 | Sell |
| ADX (14) | 22.14 | Sell |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 40, and the stock trades around the moving averages, with a SMA50 of $1.11 and a SMA200 of $1.68. Key support is $0.77 and resistance is $1.22. The 30-day price range spans $0.5688 to $1.21, and the current price of $0.83 sits within this range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.77 | $0.7834 | $0.9145 | 0% | Neutral | |
| $0.5438 | $0.7496 | $1.12 | -4% | Neutral | |
| $0.4775 | $0.6995 | $1.11 | -11% | Neutral | |
| $0.3522 | $0.5435 | $0.9062 | -31% | Bearish | |
| $0.392 | $0.6341 | $1.10 | -19% | Bearish | |
| $0.4562 | $0.7713 | $1.39 | -2% | Neutral | |
| $0.5018 | $0.8849 | $1.64 | +13% | Neutral | |
| $0.5052 | $0.9278 | $1.77 | +18% | Neutral | |
| $0.403 | $0.7699 | $1.50 | -2% | Neutral | |
| $0.3826 | $0.7598 | $1.52 | -3% | Neutral | |
| $0.5134 | $1.14 | $2.50 | +46% | Bullish | |
| $0.86 | $1.91 | $4.40 | +144% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.77 | $0.7834 | $0.9571 | +0.00% |
| August 2026 | $0.606 | $0.7344 | $0.9271 | -6.26% |
| September 2026 | $0.5869 | $0.7212 | $0.9294 | -1.79% |
| October 2026 | $0.5934 | $0.7382 | $0.9679 | +2.35% |
| November 2026 | $0.565 | $0.7101 | $0.9445 | -3.80% |
| December 2026 | $0.5347 | $0.6786 | $0.9145 | -4.44% |
Click any year to see its month-by-month IVVD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, IVVD could reach as high as $0.9145, with a base case around $0.7834 and support toward $0.77 — roughly 0% from $0.7834. Price action looks broadly range-bound.
Expect IVVD to range from $0.5438 to $1.12 through 2027. The $0.7496 average target implies a -4% move from current prices. That is -4% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The IVVD price prediction for 2028 points to an average of $0.6995 (low $0.4775, high $1.11) — a potential decline of -11% on today's $0.7834. Price action looks broadly range-bound.
In 2029, IVVD is projected to trade between $0.3522 and $0.9062, averaging $0.5435 — a potential decline of -31% from today's $0.7834. That is -22% versus the projected 2028 average. Expect choppier, lower action through this leg of the cycle.
Invivyd, Inc.'s 2030 outlook centres on $0.6341, within a $0.392 to $1.10 range. That is up +17% on the projected 2029 average. That marks a -19% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2031, IVVD could reach as high as $1.39, with a base case around $0.7713 and support toward $0.4562 — roughly -2% from $0.7834. A consolidation phase looks the most probable path here.
Expect IVVD to range from $0.5018 to $1.64 through 2032. The $0.8849 average target implies a +13% move from current prices. That is up +15% on the projected 2031 average. Price action looks broadly range-bound.
The IVVD price prediction for 2033 points to an average of $0.9278 (low $0.5052, high $1.77) — a potential gain of +18% on today's $0.7834. A consolidation phase looks the most probable path here.
In 2034, IVVD is projected to trade between $0.403 and $1.50, averaging $0.7699 — a potential decline of -2% from today's $0.7834. That is -17% versus the projected 2033 average. Price action looks broadly range-bound.
Invivyd, Inc.'s 2035 outlook centres on $0.7598, within a $0.3826 to $1.52 range. That is -1% versus the projected 2034 average. That marks a -3% change versus current levels. A consolidation phase looks the most probable path here.
By 2040, IVVD could reach as high as $2.50, with a base case around $1.14 and support toward $0.5134 — roughly +46% from $0.7834. Momentum favours further upside here.
Expect IVVD to range from $0.86 to $4.40 through 2050. The $1.91 average target implies a +144% move from current prices. That is up +68% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in IVVD today (≈ 1,276.487107 IVVD) could be worth
$2,439.6
+$1,439.6 (+144%) by 2050 · US Dollar
Based on the average projected IVVD price of $1.91 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IVVDwould be worth at today's price.
$1,000 invested in IVVD on Jul 10, 2025 (≈ 1,342.281871 IVVD) would be worth
$1,051.54
+$51.54 (+5.2%) today · 1.05× · US Dollar
Based on a IVVD entry price of $0.745 vs. today's $0.7834.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.894 | $876.29 | -12.4% |
| 1 month ago | $0.901 | $869.48 | -13.1% |
| 3 months ago | $1.76 | $445.11 | -55.5% |
| 6 months ago | $2.45 | $319.76 | -68.0% |
| 1 year ago | $0.745 | $1,051.54 | +5.2% |
| All time (4.9y) ago | $20.88 | $37.52 | -96.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IVVD forecast.
Our base-case forecast reaches $1.60 around 2050.
Implied market cap at $1.60: $471.37M
The multi-year forecast shows a path from near-term softness to longer-run upside. In 2029 the avg price is $0.566 with ROI -31.8% (BEARISH), and in 2030 the avg price is $0.679 with ROI -18.2% (BEARISH). The forecast turns more bullish by 2040, with an avg of $1.22 and ROI 47% (BULLISH), and remains strongly bullish by 2050 at an avg of $2.10 and ROI 152.8% (BULLISH).
The 2031–2033 points are modestly positive, and the long-horizon upside reflects potential gains into the 2040s. These estimates are not guarantees and depend on market conditions and execution.
Tap a question to reveal the answer.
2030 avg $0.679; ROI -18.2; sentiment BEARISH. The min is $0.4196 and the max is $1.18.
Near-term forecasts show weaker results (e.g., 2029 avg $0.566 and ROI -31.8), but the long-term view turns positive with 2040 avg $1.22 and 2050 avg $2.10, ROI 47% and 152.8% respectively. These are estimates, not guarantees.
Avg $1.22; ROI 47; sentiment BULLISH. The min is $0.549 and the max is $2.68.
Current price is $0.83 and market cap is $244.52M.
30-day range low $0.5688 and high $1.21; support $0.77; resistance $1.22; RSI14 40; SMA50 $1.11; SMA200 $1.68. Current price $0.83 sits within the range.
Invivyd, Inc. Community Discussion
0Share your Invivyd, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.